C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2006
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258656 Compositions and methods for treating cancer
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production
11/16/2006	CA2608248A1 Soluble epoxide hydrolase inhibitors and methods of using same
11/16/2006	CA2608194A1 Compounds for modulating trpv3 function
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	CA2607917A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/15/2006	EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006	EP1721604A1 Stable capsule preparation
11/15/2006	EP1720874A1 4-substituted piperidine derivatives
11/15/2006	EP1720872A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
11/15/2006	EP1720870A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720865A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
11/15/2006	EP1720863A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
11/15/2006	EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
11/15/2006	EP1720859A2 Chemokine receptor antagonists
11/15/2006	EP1720858A1 Crystal forms of e-2-methoxy-n-(3-{4- [3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino -quinazolin-6-yl}-allyl)-acetamide
11/15/2006	EP1720857A1 Dihydropyridinone derivatives
11/15/2006	EP1720856A2 Hiv integrase inhibitors
11/15/2006	EP1720855A1 Inhibitors of akt activity
11/15/2006	EP1720854A1 Phthalzinone derivatives as pde4 inhibitors
11/15/2006	EP1720853A1 Novel polymorphic form of imatinib mesylate and a process for its preparation
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720843A2 Process for the preparation of substituted triazole compounds
11/15/2006	EP1720841A2 Quinazoline derivatives and therapeutic use thereof
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3
11/15/2006	EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006	EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006	EP1720513A1 Lightening direct dyestuffs for keratin fibers and dyes containing said compounds
11/15/2006	EP1562907B1 Pyridine derivatives as cb2 receptor modulators
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1448549B1 Delta1-pyrrolines
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1863795A P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
11/15/2006	CN1863794A Quinazoline derivatives as angiogenesis inhibitors
11/15/2006	CN1863792A Novel farnesyl protein transferase inhibitors as antitumor agents
11/15/2006	CN1863791A Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
11/15/2006	CN1863790A Therapeutic agents useful for treating pain
11/15/2006	CN1863789A Substituted isoquinolinones
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863780A Protein kinase inhibitors and uses thereof
11/15/2006	CN1863779A Novel indazole derivative
11/15/2006	CN1863777A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
11/15/2006	CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006	CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
11/15/2006	CN1863532A Aza spiro alkane derivatives as inhibitors of metalloproteases
11/15/2006	CN1863528A Indoles and azaindoles as antiviral agents
11/15/2006	CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
11/15/2006	CN1863459A 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
11/15/2006	CN1861632A Coupling compound of Norfloxacin, preparation process and application thereof
11/15/2006	CN1861599A Quinone carboxylic acid kind derivant, it preparation process and medicine application
11/15/2006	CN1861596A Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/15/2006	CN1284773C Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135468 Antibacterial compounds
11/14/2006	US7135467 HIV integrase inhibitors
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2274669C 1,5-benzodiazepine derivatives
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/12/2006	CA2546392A1 Phenylpyridinylpiperazine derivatives, a process for their preparation and pharmaceutical compositions containing them
11/12/2006	CA2546387A1 Phenyl-pyridinyl-piperazine derivatives, process for the preparation thereof and pharmaceutical compositions containing said derivatives
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	WO2006119417A1 Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
11/09/2006	WO2006119400A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
11/09/2006	WO2006118534A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
11/09/2006	WO2006118267A1 Anthranylamide compound, process for producing the same and pest control agent containing the compound
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118231A1 Cyanopyridine derivative and use thereof as medicine
11/09/2006	WO2006118212A1 Agent for preventing and treating pancreatitis

1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 1080